BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

講師

Roberto Gardellin

Session 14 – CDMO Business for Small Molecules

Date:29 July (Friday)
Time:  14:00 – 15:30 (GMT+8)

Roberto Gardellin

Global Health, Serialization & EMG Risk Management Head
Sanofi

.​

Chemical Engineer
I started to work in the API manufacturing site of a Sanofi predecessor company just after university, spending seventeen years three continents and in various roles in manufacturing, Engineering, HSE, and R&D for Biotech and Small Molecules API.
Since 2006 I have been working in Sanofi External Manufacturing at the Paris Industrial Affairs Headquarter, dealing with special projects and production and development of API and Drug Products at CRO/CDMO/CMOs, among them a few projects finalize to the development of new DS and oral dosage form drug products against the HAT or sleeping sickness, a sub-saharian Africa neglected disease whose elimination by 2030 is one of the most important Corporate Social Responsibility goals for Sanofi.

Speech title & Synopsis

.

.